Patents by Inventor Lane Desborough

Lane Desborough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10780223
    Abstract: A method includes receiving up-to-date blood glucose data for a PWD, determining basal insulin dosages for the PWD based on a baseline basal rate, delivering the basal insulin dosages to the PWD, modifying a target blood glucose level based on variability of blood glucose data for the PWD, receiving a temporary override indicating a user preference to reduce the likelihood that the PWD has a hypoglycemic event or a user preference to reduce the likelihood that the PWD has a hyperglycemic event, determining a temporary target blood glucose level based on the input—greater than the modified blood glucose level if the preference is to reduce the likelihood of a hypoglycemic event—lower than the modified target blood glucose level if the preference is to reduce the likelihood that of a hyperglycemic event. The method includes delivering basal insulin for the temporary period of time based on the temporary target.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: September 22, 2020
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish
  • Patent number: 10758675
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include receiving and/or determining one or more user specific dosage parameters.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: September 1, 2020
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20200215267
    Abstract: Methods of insulin delivery may include obtaining one or more blood glucose readings from a flash glucose monitor, where the blood glucose readings may be obtained in response to a user invocation of the flash glucose monitor. The method may also include generating multiple insulin delivery profiles of insulin delivery actions over multiple diurnal time segments based on the one or more blood glucose readings. The method may additionally include selecting one of the delivery profiles that is projected to approximate a target blood glucose level, and delivering insulin according to the selected delivery profile. Systems may provide such insulin delivery.
    Type: Application
    Filed: March 18, 2020
    Publication date: July 9, 2020
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20200206421
    Abstract: Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.
    Type: Application
    Filed: February 27, 2020
    Publication date: July 2, 2020
    Inventors: Bryan Mazlish, Lane Desborough, Ravi Shankar Rontala Raghunathan
  • Publication number: 20200197608
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 25, 2020
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20200108204
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 10610644
    Abstract: Methods of insulin delivery may include obtaining one or more blood glucose readings from a flash glucose monitor, where the blood glucose readings may be obtained in response to a user invocation of the flash glucose monitor. The method may also include generating multiple insulin delivery profiles of insulin delivery actions over multiple diurnal time segments based on the one or more blood glucose readings. The method may additionally include selecting one of the delivery profiles that is projected to approximate a target blood glucose level, and delivering insulin according to the selected delivery profile. Systems may provide such insulin delivery.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: April 7, 2020
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 10610643
    Abstract: Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: April 7, 2020
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ravi Shankar Rontala Raghunathan
  • Patent number: 10583250
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: March 10, 2020
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 10525200
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves obtaining a sequence of measurements indicative of a condition of the user that is influenced by the fluid and modifying one or more unusable measurements in the sequence using one or more other usable measurements in the sequence to obtain a modified sequence of measurements. The method continues by determining a predicted value for the condition of the user at a time in the future based at least in part on the modified sequence of measurements and operating the infusion device in a manner that is influenced by the predicted value.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: January 7, 2020
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Cesar C. Palerm, Louis J. Lintereur, Salman Monirabbasi, Kris R. Holtzclaw, Lane Desborough
  • Publication number: 20200001018
    Abstract: One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
    Type: Application
    Filed: September 10, 2019
    Publication date: January 2, 2020
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Per J. Sjoelund
  • Publication number: 20200000384
    Abstract: Disclosed are methods, apparatuses, etc. for determination and application of a metric for assessing a patient's glycemic health. In one particular implementation, a computed metric may be used to balance short-term and long-term risks associated with a particular therapy.
    Type: Application
    Filed: July 10, 2019
    Publication date: January 2, 2020
    Inventors: Lane Desborough, Cesar C. Palerm, Salman Monirabbasi
  • Patent number: 10500334
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: December 10, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 10426896
    Abstract: One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: October 1, 2019
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: Lane Desborough, Bryan Mazlish, Andrew Bochenko, Ross Naylor, Per John Sjölund
  • Patent number: 10390740
    Abstract: Disclosed are methods, apparatuses, etc. for determination and application of a metric for assessing a patient's glycemic health. In one particular implementation, a computed metric may be used to balance short-term and long-term risks associated with a particular therapy.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: August 27, 2019
    Assignee: Medtronic Minimed, Inc.
    Inventors: Lane Desborough, Cesar Palerm, Salman Monirabbasi
  • Publication number: 20190247578
    Abstract: A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 15, 2019
    Inventors: Lane Desborough, Bryan Mazlish
  • Publication number: 20190221307
    Abstract: A diabetes management system including a pump for dispensing a medicant and a control device for controlling the pump includes a user interface for controlling functions of the pump and providing information related to operation of the pump and other information. The user interface can display blood glucose information and insulin dosing data such that a user can appropriately act on the information and/or gain confidence that the diabetes management system is operating appropriately to manage the disease. User interfaces provided herein can include displays of current and projected glucose values, bolus calculators, charts displaying glucose levels and/or insulin delivery data, system maintenance reminders, system status information, patient configuration input screens, and log-in screens. Diabetes management systems can include insulin pumps, continuous glucose monitors, blood glucose monitors, mobile computing devices, servers, and/or other insulin delivery devices (e.g., insulin pens).
    Type: Application
    Filed: March 21, 2019
    Publication date: July 18, 2019
    Inventors: Bryan Mazlish, Jeffrey Brewer, Lane Desborough, Jennifer Block, Robert Weishar, Alan Schachtely
  • Publication number: 20190184111
    Abstract: One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 20, 2019
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20190184108
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 20, 2019
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20190184107
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 20, 2019
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak